Glaxo to Pay $3 Billion for
Unapproved Marketing of Paxil & Wellbutrin

By
-
1
105

In agreeing to settle the largest case of health care fraud in U.S. history, GlaxoSmithKline pled guilty today to marketing Paxil for teens and children and to advertising Wellbutrin for weight loss and sexual dysfuntion. Glaxo will pay $1 billion in criminal fines and $2 billion in civil fines for activities such as distributing a misleading journal article and providing kickbacks to doctors. “Today’s historic settlement is a major milestone in our efforts to stamp out health care fraud,” said the deputy secretary of health and human services in a statement. Article →  Related Item: GlaxoSmithKline settles healthcare fraud case for $3 billion Glaxo Agrees to Pay $3 Billion in Fraud Settlement

***

Mad in America hosts blogs by a diverse group of writers. These posts are designed to serve as a public forum for a discussion—broadly speaking—of psychiatry and its treatments. The opinions expressed are the writers’ own.

Previous articleSpiritual Recovery
Next articleSpanking is Associated With Mental Illness
Kermit Cole
Kermit Cole
Kermit Cole, MFT, founding editor of Mad in America, works in Santa Fe, New Mexico as a couples and family therapist. Inspired by Open Dialogue, he works as part of a team and consults with couples and families that have members identified as patients. His work in residential treatment — largely with severely traumatized and/or "psychotic" clients — led to an appreciation of the power and beauty of systemic philosophy and practice, as the alternative to the prevailing focus on individual pathology. A former film-maker, he has undergraduate and master's degrees in psychology from Harvard University, as well as an MFT degree from the Council for Relationships in Philadelphia. He is a doctoral candidate with the Taos Institute and the Free University of Brussels. You can reach him at [email protected].

1 COMMENT

LEAVE A REPLY